Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $709,990.00 |
|---|---|
| Enterprise Value | $3.65 Million |
| Earnings per Share | $-0.05 |
| Beta | -1.47 |
| Outstanding Shares | 105,968,663 |
| P/E Ratio | -0.15 |
|---|---|
| PEG | -0.02 |
| Price to Sales | - |
| Price to Book Ratio | -0.01 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -7.45 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.84 |
| Debt to Equity | -0.25 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Odyssey Health, Inc. operates as a medical enterprise, primarily focused on the innovation and development of diverse healthcare products. Its current portfolio encompasses CardioMap, an advanced device for cardiac monitoring and screeni...